Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001033339 | SCV001196646 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2022-10-17 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 16-19 of the MLH1 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. A similar copy number variant has been observed in individual(s) with Lynch syndrome, colon cancer and/or sebaceous skin cancer (PMID: 14635101, 15713769, 16143124). It has also been observed to segregate with disease in related individuals. This variant disrupts the C-terminal PMS2 interaction domain of the MLH1 protein, which is necessary for proper MLH1-PMS2 dimerization and normal protein function (PMID: 10037723, 11793442, 16083711). While functional studies have not been performed to directly test the effect of this variant on MLH1 protein function, this suggests that disruption of this region of the protein is causative of disease. For these reasons, this variant has been classified as Pathogenic. |